We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Melrose Industries Plc | LSE:MRO | London | Ordinary Share | GB00BNGDN821 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.18% | 554.20 | 553.00 | 553.60 | 560.40 | 546.20 | 553.40 | 1,581,232 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
National Security | 4.93B | -1.02B | -0.7808 | -7.09 | 7.25B |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2020 13:16 | Yes, Yertiz, thank you. Just a bit of a flare up of the old arthritic hands due to the weather, I expect. Do you miss old brexitplus's lifestyle bulletins, as I certainly do? "Just done a 12 mile stroll this morning, followed by a huge pub lunch. 'Chicken on Horseback' for dinner tonight. | meanwhile | |
22/4/2020 12:44 | Keeping well, Meanwhile? | yertiz | |
22/4/2020 11:38 | Professor Carl Heneghan, Director of the centre for evidence-based medicine at Oxford University, believes the Coronavirus outbreak peeked back in March and that the true fatality rate in the U.K. is likely to be in the range of 0.1-0.3%, rather than the 5-10% of those afflicted, suggested by the bulk of UK scientific opinion. This means the true number of UK citizens who have so far contracted the virus is more like 10 Million (rather than a few hundred thousand), according with 15-20,000 resulting deaths. Heneghan's suggested low death rate goes some way to explaining why the deaths in the NHS staff (around 480,000 clinical staff) is a low figure of 100-150, to date, despite the sporadic testing of NHS staff generally showing high levels of positive results. Heneghan believes most involved NHS staff have now been exposed, along with a large proportion of the country's people, but with a low fatality rate of 0.1-0.3%. If this scenario is correct, then this epidemic/pandemic is no more serious than a very contagious influenza, claiming the lives of the weak and more susceptible, at a rate of 1 or 2 in a thousand. And, if this emerges and becomes accepted as a truer representation of the virus and its long term effects, the stock market will respond in a fashion never before seen. | meanwhile | |
22/4/2020 08:17 | It's in the press release on the GKN aerospace websiteHtTps://www.g | eldermon | |
22/4/2020 08:12 | Not sure if that’s true but even if it was, do you seriously think that’s going to make them the sort of levels of profits they need to offset losses in their core businesses? You seem to be in a dreamworld just like Meanwhile said the other day! | gettingrichslow | |
22/4/2020 07:46 | New one on me.., were did you get the information | jackdaw4243 | |
22/4/2020 06:13 | You do know gkn aerospace is helping with the ventilators right just like Rolls-Royce ? | ammu12 | |
21/4/2020 22:01 | Jackdaw, it depends on what you’re manufacturing surely? If a company is manufacturing masks and other healthcare equipment, then yes. If a company is manufacturing airplane or car parts, then no. | gettingrichslow | |
21/4/2020 14:04 | Some from ADVFN. Thought for the Day So retail is going away, airlines, restaurants, pubs, cinemas, exhibitions, sport. That cascades into advertising supported media, property companies, oil… High Street. When if that is the general thought then perhaps it will be time to buy. But buy what? And of course, buy when? Manufacturing comes to mind and companies that produce. MRO fits into that bracket along with R R and Meggit Et Al. | jackdaw4243 | |
20/4/2020 18:34 | Would be nice to pick some more up at 80 here | paulof2 | |
20/4/2020 13:17 | No that is the people who peddle them to cause pain when others are suffering all be it with an ers on the end............Can not wish for a more experienced turn around crew on the board ....think I will trust in their views...also top blokes. Although I note a W forming in their chart which may be that is what they think of short interests a bunch of W rs Nice bounce to 1.60 and ruffle a few short and curlies | seagreen | |
20/4/2020 11:06 | Gaps to infill, particularly Friday open, then down to 75 to close that one, not suggesting it will but they are there and now present! | bookbroker | |
20/4/2020 09:58 | "The business is well run. In early March the industrials group announced full-year revenues rose 34% to £ 11.6bn. Operating profits rose 35.5% to £ 1.1bn. So, assuming COVID-19 doesn’t close down the business for too long, it should come out the other end of this stronger. Especially if it means competitors go out of business, which is highly likely." Some of you are living in a world of dreams. If you expect the world to eventually 'get back to normal', you should think again. | meanwhile | |
19/4/2020 14:39 | Airbus uk site Airbus confirmed earlier Friday that employees in Broughton, Wales, and Filton, England, will resume work next Monday after a 3 1/2-week break. | ammu12 | |
19/4/2020 14:27 | The business is well run. In early March the industrials group announced full-year revenues rose 34% to £ 11.6bn. Operating profits rose 35.5% to £ 1.1bn. So, assuming COVID-19 doesn't close down the business for too long, it should come out the other end of this stronger. Especially if it means competitors go out of business, which is highly likely. | ammu12 | |
19/4/2020 13:51 | As they still have not rectified the issues with 737 MAX it is hardly worth celebrating, this company will not benefit for some time, and who is say that the work pattern will be modest at best! | bookbroker | |
19/4/2020 10:53 | 5000 order backlog wow...Boeing back to work from Monday that's good news for Melrose aerospace. Germany is already back to work so should be good for the automotive business. We should see some sort of recovery soon hopefully. | ammu12 | |
19/4/2020 10:09 | From an old report last week, I understand GKN supply via Fokker lots of bits to Boeing. So good news if they are starting production at Boeing. "Despite all the government bailouts, it’s looking pretty dire for airlines, aircraft manufacturers, and aerospace. Boeing has seen over 300 orders for its cursed 737 MAX plane cancelled – though it still has a 5000 plane backlog. Thousands of small suppliers rely on orders from the engine makers and plane makers." | jackdaw4243 | |
18/4/2020 14:04 | Again it seems like you can't let go Melrose after you've sold out and still trying to justify your sell. Let it go.....Economy is already Shyte but there is some positive last week so hopefully we should see some recovery..... | ammu12 | |
18/4/2020 13:05 | Ammu, we all know the business is well run, but unfortunately that counts for nothing when a pandemic has just shut down the global economy. I’m not sure if you are deliberately being argumentative or whether you’re just a bit dim, but you must be able to see the problem with your statement “assuming COVID-19 doesn’t close down the business for too long”? That’s the whole point - NO-ONE HAS GOT ANY IDEA WHEN THIS WILL BE OVER - read the Harvard research released a couple of days ago, or the University of Washington research if you want to see what the two world leading research organisations are saying on it. Once you’ve had a read, come back on here and tell us when you think the prospects are likely to be looking rosy for Melrose. | gettingrichslow | |
18/4/2020 12:39 | The business is well run. In early March the industrials group announced full-year revenues rose 34% to £ 11.6bn. Operating profits rose 35.5% to £ 1.1bn. So, assuming COVID-19 doesn't close down the business for too long, it should come out the other end of this stronger. Especially if it means competitors go out of business, which is highly likely. | ammu12 | |
18/4/2020 10:39 | Hence why share price is sub 100 and not 300. You reckon when this will all end share price will be this low? Not sure the point you are trying to make. | ammu12 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions